Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
X-Plorer rivaroxaban dose-finding trial in elective PCI
2011-001094-58Phase 2Completed
- Sponsor
- Bayer
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rivaroxaban in coronary arteriosclerosis, sponsored by Bayer. Started May 2011; status: completed.
02
Drugs
rivaroxaban
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2011-001094-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001094-58.